PWRM, SIGA, - DrStockPick.com Stocks to Watch!

DrStockPick.com is pleased to announce its Daily Stocks to Watch!
By: Arnu Saucedo
 
June 23, 2010 - PRLog -- DrStockPick.com is pleased to announce its Daily Stocks to Watch!

We encourage investors to join the FREE daily e-mail alerts by visiting:

http://www.drstockpick.com/signup

__

PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

** THE INTERNATIONAL CONGRESS OF ALZHEIMER’S DISEASE ACCEPTS FOUR SCIENTIFIC PRESENTATIONS BY PWRM **

Four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer’s Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the PWRM’s NuroPro AD biomarkers and blood test for Alzheimer’s disease.

The four studies to be presented involve a total of 154 Alzheimer’s disease patients and 91 Parkinson’s disease patients, as well as 210 age-matched normal control individuals and 173 disease control individuals.

- According to recent estimates, as many as 2.4 million to 4.5 million Americans have Alzheimer’s disease (AD). Unless the disease can be effectively treated or prevented, the number of people with AD will increase significantly if current population trends continue. That’s because the risk of AD increases with age, and the U.S. population is aging. The number of people age 65 and older is expected to grow from 39 million in 2008 to 72 million in 2030, and the number of people with AD doubles for every 5-year interval beyond age 65.

__

SIGA, SIGA Technologies, Inc.

SIGA, a bio-defense company, engages in the discovery, development, and commercialization of products for use in defense against biological warfare agents comprising smallpox and arenaviruses. It also involves in the discovery and development of other novel anti-infectives and antibiotics for the prevention and treatment of serious infectious diseases.

** SIGA reported the successful completion of its fourth human clinical trial, supporting the safety and tolerability of the anticipated clinical dose of ST-246(R), SIGA's lead smallpox antiviral drug candidate. Analyses of the trial's results are consistent with findings from previous studies of ST-246 and together show that the drug will likely be found to be a safe and well-tolerated therapeutic for the treatment of orthopoxvirus infections.

__

***FREE DAILY STOCK ALERTS**


Sign up to receive FREE stock alerts from DrStockPick.com at http://www.drstockpick.com/signup


About DrStockPick.com


DrStockPick.com is a stock watch website, a Crown Equity Holdings, Inc. division that provides free daily alerts on stocks. DrStockPick.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. DrStockPick.com also tracks small cap stocks that are on the brink of moving upwards. DrStockPick.com also features companies on its website with research report, analysis, and  newsletters.


DrStockPick.com is an independent electronic publication that provides information on selected publicly traded companies. DrStockPick.com is not a registered investment advisor or broker-dealer.

DrStockPick.com and Crown Equity Holdings, Inc., affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Please do your own Due Diligence before investing in any of the stocks mentioned above. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our sites, stock alerts, watch list or joining our email list. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).  Full disclaimer can be read at www.DrStockPick.com.

Release of Liability: Through use of our website, Email Alerts, and stock alerts viewing or using, you agree to hold DrStockPick.com, Crown Equity Holdings, Inc., its operators, shareholders, consultants, associates and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

DrStockPick.com and Crown Equity Holdings, Inc. affiliates and associates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Crown Equity Holdings, Inc. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and  DrStockPick.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

Forward Looking Statement

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements and changing price and market conditions. No assurance can be given that these are all the factors that could cause
actual results to vary materially from the forward-looking statements. Therefore, you should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.


Contact:

DrStockPick.com
E-mail:  arnu@drstockpick.com
Phone:  (702) 448-1543
FREE:  1-877-854-6797
FAX:  (702) 479-7151
End
Source:Arnu Saucedo
Email:***@pennyomega.com
Tags:Nasdaq: Siga, Otc:pwrm, Power 3 Medical Products, Pwrm, Pwrm Ob, Siga, Siga Technologies
Industry:Biotech, Medical, Business
Account Email Address Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share